US Patent 7041292 Treating prostate cancer with anti-ErbB2 antibodies
Patent 7041292 was granted and assigned to Genentech on May, 2006 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 23, 2000
0
Date of Patent
May 9, 2006
0
Patent Application Number
09602800
0
Patent Inventor Names
Mark X. Sliwkowski
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7041292 Treating prostate cancer with anti-ErbB2 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
